EGM
AMLX icon

Engineers Gate Manager’s Amylyx Pharmaceuticals AMLX Stock Holding History

Engineers Gate Manager’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,358
Closed -$222K – 2156
2025
Q4 		$222K Buy
+18,358
New +$249K ﹤0.01% 1764
2025
Q2 		– Sell
-13,382
Closed -$47.4K – 2131
2025
Q1 		$47.4K Sell
13,382
-4,255
-24% -$15.1K ﹤0.01% 2049
2024
Q4 		$66.7K Buy
+17,637
New +$83K ﹤0.01% 2042
2024
Q3 		– Sell
-84,044
Closed -$160K – 2092
2024
Q2 		$160K Buy
+84,044
New +$163K ﹤0.01% 1683
2024
Q1 		– Sell
-29,205
Closed -$430K – 1888
2023
Q4 		$430K Buy
29,205
+14,889
+104% +$228K 0.01% 1260
2023
Q3 		$262K Sell
14,316
-13,066
-48% -$276K 0.01% 1386
2023
Q2 		$591K Buy
27,382
+4,260
+18% +$115K 0.02% 959
2023
Q1 		$678K Buy
+23,122
New +$803K 0.03% 825

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Engineers Gate Manager's AMLX Position: Q1 2026 in Review

Engineers Gate Manager sold out of Amylyx Pharmaceuticals (AMLX) in Q1 2026, closing a stake of 18,358 shares — an estimated $222K sold.

Engineers Gate Manager first reported a position in AMLX in Q1 2023 and held it in 8 quarters. The position peaked at $678K in Q1 2023. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

  • Engineers Gate Manager reported no remaining Amylyx Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 18,358 Amylyx Pharmaceuticals shares in Q1 2026, an estimated $222K.
  • Engineers Gate Manager first reported a position in Amylyx Pharmaceuticals in Q1 2023 and held it in 8 quarters.
  • Engineers Gate Manager's Amylyx Pharmaceuticals position peaked at $678K in Q1 2023.
  • 171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.